Company profile
Biogenea Pharmaceuticals Ltd.
Privately held: no public share price (Thessaloniki-based biotech; no ticker, listing or public-financing history in registry or press records. [resolved 2026-08-05 by resolve-null-is-public; source: https://findbiz.gr/en/company/biogenea-pharmaceuticals-ltd/601000269859]) · Greece
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | Patient-specific tumor neoantigens and shared tumor-associated antigensVaccine | Non-Small Cell Lung Cancer |
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.